| PACE: Pacing to Avoid Cardiac Enlargement (PACE) study | Clinical Trial Update III | Yu, Cheuk-Man - Abraham, William
| Arrhythmias | 01 Sep 2010 |
| CARE HF LTFU: Cardiac Resynchronisation in Heart Failure: Long-Term Follow-up | Clinical Trial Update III | Cleland, John - Breithardt, Ole A
| Heart Failure (HF) | 01 Sep 2010 |
| TREAT: Trial to Reduce Cardiovascular Events with Aranesp (darbepoetin) Therapy | Clinical Trial Update III | McMurray, John - Swedberg, Karl
| Acute Coronary Syndromes (ACS) | 01 Sep 2010 |
| REALISE-AF registry: an international, observational, cross-sectional survey describing characteristics, cardiovascular risk, and management of patients with atrial fibrillation | Clinical Trial Update III | Steg, Philippe Gabriel - Brugada Terradellas, Josep
| Arrhythmias | 01 Sep 2010 |
| KYOTO HEART: Effect of valsartan on cardiovascular outcomes in patients with high-risk hypertension: updated analyses of the KYOTO HEART Study | Clinical Trial Update III | Matsubara, Hiroaki - Laurent, Stephane
| Hypertension | 01 Sep 2010 |
| JIKEI HEART: Effect of valsartan in Japanese subjects with coronary heart disease: Sub-analysis of results of JIKEI HEART Study | Clinical Trial Update III | Shimizu, Mitsuyuki - Maggioni, Aldo Pietro
| Hypertension | 01 Sep 2010 |
| DANPACE: The Danish multicenter randomised trial on single lead atrial versus dual chamber pacing in sick sinus syndrome | Hot Line III - Cardiovascular disease and rhythm disturbances | Nielsen, Jens Cosedis - Blomstrom-Lundqvist, Carina
| Arrhythmias | 31 Aug 2010 |
| RESPONSE: Effect of a nurse coordinated prevention program on cardiovascular risk after an acute coronary syndrome: Main results of the RESPONSE trial | Hot Line III - Cardiovascular disease and rhythm disturbances | Peters, Ron J G - Deaton, M Christi
| Cardiovascular Disease Prevention - Risk Assessment and Management | 31 Aug 2010 |
| AVERROES: Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Strokes | Hot Line III - Cardiovascular disease and rhythm disturbances | Connolly, Stuart J - Arnesen, Harald
| Peripheral Arterial Diseases | 31 Aug 2010 |
| EINSTEIN DVT: Oral rivaroxaban versus standard therapy in the initial treatment of symptomatic deep vein thrombosis and long-term prevention of recurrent venous thromboembolism | Hot Line III - Cardiovascular disease and rhythm disturbances | Buller, Harry - Darius, Harald
| Thromboembolic Venous Disease | 31 Aug 2010 |
| ANTIPAF: Angiotensin II-antagonist in paroxysmal atrial fibrillation trial | Hot Line III - Cardiovascular disease and rhythm disturbances | Goette, Andreas - Camm, John
| Arrhythmias | 31 Aug 2010 |
| FUTURA OASIS 8: A randomised trial comparing two regimens of adjunctive intravenous unfractionated heparin during PCI in high-risk patients with non-STE-ACS treated with fondaparinux | Hot Line III - Cardiovascular disease and rhythm disturbances | Jolly, Sanjit - Dudek, Dariusz
| Acute Coronary Syndromes (ACS) | 31 Aug 2010 |
| INNOVATE PCI: A Phase II Safety and Efficacy Study of PRT060128 (Elinogrel), a Novel Intravenous and Oral P2Y12 Inhibitor, in Non-Urgent PCI. | Hot Line II - Coronary artery disease | Rao, Sunil - Kristensen, Steen Dalby
| Acute Coronary Syndromes (ACS) | 30 Aug 2010 |
| ART: A randomised trial to compare survival following bilateral versus single internal mammary (IMA) grafting in coronary revascularisation | Hot Line II - Coronary artery disease | Taggart, David - Kappetein, A Pieter
| Acute Coronary Syndromes (ACS) | 30 Aug 2010 |
| LESSON I: Long-term comparison of Everolimus-eluting and Sirolimus-eluting Stents for coronary revascularisation | Hot Line II - Coronary artery disease | Windecker, Stephan - Widimsky, Petr
| Acute Coronary Syndromes (ACS) | 30 Aug 2010 |
| ATOLL: An international, randomized trial comparing i.v. enoxaparin with i.v. unfractionated heparin in primary PCI for ST-elevation myocardial infarction | Hot Line II - Coronary artery disease | Montalescot, Gilles - White, Harvey
| Acute Coronary Syndromes (ACS) | 30 Aug 2010 |
| ISAR REACT 3A: A trial of reduced dose of unfractionated heparin in patients undergoing percutaneous coronary interventions | Hot Line II - Coronary artery disease | Schulz, Stefanie - Hamm, Christian
| Acute Coronary Syndromes (ACS) | 30 Aug 2010 |
| Double-blind, placebo-controlled phase II studies of E5555 in Japanese patients with Acute Coronary Syndrome (ACS) and Coronary Artery Disease (CAD) | Hot Line II - Coronary artery disease | Goto, Shinya - Van de Werf, Frans
| Acute Coronary Syndromes (ACS) | 30 Aug 2010 |
| COPPS: COlchicine for the Prevention of the Post-pericardiotomy Syndrome: results of the COPPS trial, a multicentre, double-blind, randomised trial | Clinical Trial Update II | Imazio, Massimo - Keren, Andre
| Pericardial Disease | 30 Aug 2010 |
| REACH Registry: Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or with Atherothrombosis: Final Follow-Up from the International REACH Registry | Clinical Trial Update II | Bhatt, Deepak - Andreotti, Felicita
| Chronic Ischaemic Heart Disease (IHD) | 30 Aug 2010 |
| ACCESS: Acute coronary syndromes (ACS) in Africa, middle-east and latin america: the access registry | Clinical Trial Update II | Sobhy, Mohamed - Lopez-Sendon, Jose
| Acute Coronary Syndromes (ACS) | 30 Aug 2010 |
| EHS ACS III: Euro Heart Survey Acute Coronary Syndromes III | Clinical Trial Update II | Schiele, Francois - Danchin, Nicolas
| Acute Coronary Syndromes (ACS) | 30 Aug 2010 |
| GRACE: Five year outcomes (UK Belgian collaboration) | Clinical Trial Update II | Fox, Keith - Verheugt, Freek
| Acute Coronary Syndromes (ACS) | 30 Aug 2010 |
| RIKS HIA: Survival benefits by 12 years registry supported improvement of acute cardiac care in the Sweden - the RIKS-HIA 12 years study | Clinical Trial Update II | Jernberg, Tomas - Price, Susanna
| Acute Coronary Syndromes (ACS) | 30 Aug 2010 |
| Hyperosmolarity caused by high levels of glucose and mannitol induces angiogenesis by activating the Tonicity-responsive cis-acting elements, aquaporin 1- and Na+/H+ exchanger 1 and COX-2 and MMPs in human endothelial cells | Science Hot Line | Madonna, Rosalinda
| Clinical pharmacology | 30 Aug 2010 |
| "Remote preconditioning reflex" - a neural pathway of cardioprotection during myocardial ischaemia and reperfusion induced by remote ischaemic preconditioning | Science Hot Line | Gourine, Andrey
| Acute Coronary Syndromes (ACS) | 30 Aug 2010 |
| Proteomic analysis of smooth muscle cells derived from carotid plaque reveals differences between symptomatic & asymptomatic plaques | Science Hot Line | Full, Louise
| Chronic Ischaemic Heart Disease (IHD) | 30 Aug 2010 |
| Galectin-2 expression is dependent on the rs7291467 single nucleotide polymorphism and suppresses collateral artery growth | Science Hot Line | van der Laan, Anja
| Clinical pharmacology | 30 Aug 2010 |
| Haptoglobin deficiency causes cardiac rupture and adverse remodeling after myocardial infarction | Science Hot Line | Arslan, Fatih
| Acute Coronary Syndromes (ACS) | 30 Aug 2010 |
| Telomerase and Myocardin-A synergistically regulates expression of promyogenic transcription factors in mesenchymal stem cells of adult adipose tissue | Science Hot Line | Geng, Yong
| Clinical pharmacology | 30 Aug 2010 |
| SHIFT: Heart rate in heart failure: risk marker or risk factor? A sub-analysis of the SHIFT trial | Clinical Trial Update II | Böhm, Michael - Kjekshus, John
| Heart Failure (HF) | 30 Aug 2010 |
| STAR Heart Study: the acute and long-term effect of intracoronary stem cell transplantation in 191 patients with chronic heart failure | Hot Line I - Heart failure and left ventricular dysfunction | Strauer, Bodo-Eckehard - Fernandez-Aviles, Francisco
| Heart Failure (HF) | 29 Aug 2010 |
| PEARL HF: Multicenter, randomized, double-blind, placebo-controlled, parallel-group, multiple-dose study to evaluate the effects of RLY5016 in heart failure patients | Hot Line I - Heart failure and left ventricular dysfunction | Pitt, Bertram - Dargie, Henry J
| Heart Failure (HF) | 29 Aug 2010 |
| SHIFT: Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction | Hot Line I - Heart failure and left ventricular dysfunction | Komajda, Michel - Anand, Inder
| Heart Failure (HF) | 29 Aug 2010 |
| ALPHA OMEGA: Effect of low doses of n-3 fatty acids on cardiovascular diseases in post-MI patients | Hot Line I - Heart failure and left ventricular dysfunction | Kromhout, Daan - Tavazzi, Luigi
| Rehabilitation and Exercise Physiology | 29 Aug 2010 |
| HEBE III: A single dose of erythropoietin in ST-elevation myocardial infarction | Hot Line I - Heart failure and left ventricular dysfunction | Voors, Adriaan - Ponikowski, Piotr
| Acute Coronary Syndromes (ACS) | 29 Aug 2010 |
| EVOLUTION: Clinical EValuation Of the Edwards Lifesciences percUTaneous mItral annulOplasty system for the treatment of mitral regurgitatioN | Clinical Trial Update I | Harnek, Jan - Antunes, Manuel J
| Valvular Heart Diseases | 29 Aug 2010 |
| MULTI STRATEGY: 3-year Follow-up of the Comparison of Angioplasty with Infusion of Tirofiban or Abciximab and with Implantation of Sirolimus-Eluting or Uncoated Stents for Acute Myocardial Infarction | Clinical Trial Update I | Valgimigli, Marco - Serruys, Patrick
| Acute Coronary Syndromes (ACS) | 29 Aug 2010 |
| ISAR TEST 4: Two-year Clinical Outcomes from a Randomized Trial of Biodegradable Polymer Drug-Eluting Stents Versus Permanent Polymer Cypher and Xience Drug-Eluting Stents | Clinical Trial Update I | Byrne, Robert - Marco, Jean
| Acute Coronary Syndromes (ACS) | 29 Aug 2010 |
| PLATO genetic substudy: Impact of CYP2C19 and ABCB1 single nucleotide polymorphisms (SNPs) on outcomes with ticagrelor and clopidogrel in acute coronary syndrome - a PLATO genetic substudy | Clinical Trial Update I | Wallentin, Lars - Huber, Kurt
| Acute Coronary Syndromes (ACS) | 29 Aug 2010 |
| SOURCE REGISTRY TAVI: Development of a risk score for transcatheter aortic valve implantation: 1-year outcomes from over 1,000 patients in the source registry | Clinical Trial Update I | Wendler, Olaf - Schuler, Gerhard
| Valvular Heart Diseases | 29 Aug 2010 |
| CURE ACTIVE: Efficacy and Safety of Clopidogrel compared with Placebo according to CYP2C19 Genotype in over 6000 patients with Non-ST-elevation Acute Coronary Syndromes (CURE trial) and atrial fibrillation (ACTIVE trial) | Clinical Trial Update I | Pare, Guillaume - Califf, Robert M
| Clinical pharmacology | 29 Aug 2010 |